Clinical Trials Logo

Prostatic Hypertrophy clinical trials

View clinical trials related to Prostatic Hypertrophy.

Filter by:
  • None
  • Page 1

NCT ID: NCT05023824 Recruiting - Clinical trials for Prostatic Hyperplasia

Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH

Start date: December 8, 2020
Phase: Phase 3
Study type: Interventional

The investigators compare the efficacy of alpha-blocker and 5-ARI withdrawal to continued combination therapy on the maintenance of LUTS and improvement of quality of life outcomes in men with benign prostatic hyperplasia.

NCT ID: NCT04761224 Active, not recruiting - Clinical trials for Prostatic Hypertrophy

Impact of Intraoperative Instillation of Normothermal Saline on the Prevention of Intraoperative Hypothermia and Perioperative Morbidity of Prostatic Enucleation With Holmium Laser

THERMHOLEP
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

For the treatment of benign prostatic hyperplasia (BPH), 2 types of endoscopic surgery are currently performed: transurethral prostate resection (TPR), the reference surgery, and laser prostatic enucleation (LPE). These procedures can be performed under general anesthesia, or local anesthesia, such as spinal anesthesia. The EPL or RTUP procedure requires the instillation of continuous intra-vesical fluids throughout the procedure. These 3L bags are often kept at the ambient temperature of the operating room (around 17°C): the temperature of the instilled solution is therefore much lower than the average body temperature of the patient (37°C). Thus, and by heat exchange, it often results in per and postoperative hypothermia, which is all the more frequent and profound the longer the duration of the operation. In spite of the usual procedures of warming by heating blanket, the prevalence of hypothermia, defined as a body temperature < 36°C, is 53.5% during surgical procedures. This hypothermia is all the more frequent and profound the older the patient is and the longer the duration of anesthesia. Several studies have shown that hypothermia is particularly frequent during abdomino-pelvic surgery, notably due to pathophysiological phenomena induced by anesthetic procedures. Indeed, general anesthesia, or major locoregional anesthesia, disrupts the thermoregulation center upon anesthetic induction, with alteration of peripheral vasoconstriction and tremor capacity, leading to a rapid redistribution of body heat from the center to the periphery. Through exchanges with the environment, this results in a rapid linear decrease in central body temperature that exceeds the metabolic energy produced. However, anesthetic procedures are not the only cause of hypothermic intraoperative phenomena. It has been shown that the decrease in body temperature associated with most genitourinary endoscopic procedures is multifactorial, taking into account the patient's body mass, the volume of fluids instilled, and the type and duration of the operation.

NCT ID: NCT04514718 Not yet recruiting - Quality of Life Clinical Trials

Low Energy HoLEP on IPSS

Start date: August 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)

NCT ID: NCT03318991 Enrolling by invitation - Clinical trials for Prostatic Hypertrophy

Clinical Outcomes of Laser Prostatectomy

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Benign prostate obstruction (BPO) can be treated with a range of laser treatments using different laser systems and applications. Transurethral laser treatment is considered to be an alternative treatment to transurethral resection of the prostate (TURP). The latest guidelines of the European Association of Urology recommend 532-nm GreenLight laser vaporisation of the prostate and thulium laser enucleation as alternatives to TURP. For further investigation of the efficacy of GreenLight and thulium laser in treating BPH, the investigators organize a prospective randomised control study. The investigators will enrol 100 patients with BPO, treated with either GreenLight laser or thulium laser prostatectomy, and compare their safety and efficacy.

NCT ID: NCT02943070 Completed - Clinical trials for Benign Prostatic Hyperplasia

Rezum I Pilot Study for Benign Prostatic Hyperplasia

Rezum Pilot
Start date: March 2012
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of the Rezum System for the treatment of BPH

NCT ID: NCT02940392 Completed - Clinical trials for Benign Prostatic Hyperplasia

Rezum FIM Optimization Study

Rezum FIM
Start date: March 19, 2012
Phase: N/A
Study type: Interventional

Evaluate the effect of the NxThera BPH Rezum System on prostate tissue in subjects suffering from LUTS symptoms secondary to benign prostatic hyperplasia (BPH).

NCT ID: NCT02592473 Recruiting - Clinical trials for Prostatic Hyperplasia

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this project is to evaluate the safety, efficacy, and feasibility of performing prostatic artery embolization (PAE) using endovascular techniques and particle embolics in men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).